DE69907139T2 - Verfahren zur angiostatinrückfaltung - Google Patents

Verfahren zur angiostatinrückfaltung Download PDF

Info

Publication number
DE69907139T2
DE69907139T2 DE69907139T DE69907139T DE69907139T2 DE 69907139 T2 DE69907139 T2 DE 69907139T2 DE 69907139 T DE69907139 T DE 69907139T DE 69907139 T DE69907139 T DE 69907139T DE 69907139 T2 DE69907139 T2 DE 69907139T2
Authority
DE
Germany
Prior art keywords
angiostatin
refolding method
disclosed
refolding
subfragments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69907139T
Other languages
English (en)
Other versions
DE69907139D1 (de
Inventor
N Violand
O Polazzi
F Casperson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of DE69907139D1 publication Critical patent/DE69907139D1/de
Application granted granted Critical
Publication of DE69907139T2 publication Critical patent/DE69907139T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6435Plasmin (3.4.21.7), i.e. fibrinolysin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21007Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DE69907139T 1998-01-12 1999-01-11 Verfahren zur angiostatinrückfaltung Expired - Fee Related DE69907139T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7124798P 1998-01-12 1998-01-12
PCT/US1999/000048 WO1999035248A2 (en) 1998-01-12 1999-01-11 Method of refolding angiostatin

Publications (2)

Publication Number Publication Date
DE69907139D1 DE69907139D1 (de) 2003-05-28
DE69907139T2 true DE69907139T2 (de) 2004-01-29

Family

ID=22100170

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69907139T Expired - Fee Related DE69907139T2 (de) 1998-01-12 1999-01-11 Verfahren zur angiostatinrückfaltung

Country Status (8)

Country Link
EP (1) EP1047771B1 (de)
AT (1) ATE238414T1 (de)
AU (1) AU2101599A (de)
DE (1) DE69907139T2 (de)
DK (1) DK1047771T3 (de)
ES (1) ES2198879T3 (de)
PT (1) PT1047771E (de)
WO (1) WO1999035248A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1096945A4 (de) * 1998-07-14 2003-01-02 Bristol Myers Squibb Co Angiostatinfragmente, welche an lysin binden
US6723536B2 (en) 1999-12-03 2004-04-20 Entremed, Inc. Method of producing and purifying angiostatin
CA2367198A1 (en) * 1999-12-03 2001-06-07 Entremed, Inc. Method of producing and purifying angiostatin protein
IL152804A0 (en) 2000-05-16 2003-06-24 Bolder Biotechnology Inc Methods for refolding proteins containing free cysteine residues
AU2001285919B2 (en) 2000-09-05 2007-08-23 Jiangsu Simcere Pharmaceutical R&D Co., Ltd Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen
CN101730740A (zh) * 2006-09-29 2010-06-09 蛋白质组技术公司 用于生产重组纤溶酶原和纤溶酶多肽的方法
US8617531B2 (en) 2006-12-14 2013-12-31 Bolder Biotechnology, Inc. Methods of making proteins and peptides containing a single free cysteine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2047063A1 (en) * 1991-07-15 1993-01-16 Warren C. Mackellar Method for folding tissue plasminogen activators and erivatives thereof
EP0910571B1 (de) * 1996-05-03 2005-07-20 Abbott Laboratories Antiangiogenische peptiden, dafür kodierende polynukleotide und verfahren zur hemmung der angiogenesis

Also Published As

Publication number Publication date
DE69907139D1 (de) 2003-05-28
EP1047771A2 (de) 2000-11-02
EP1047771B1 (de) 2003-04-23
ATE238414T1 (de) 2003-05-15
PT1047771E (pt) 2003-08-29
WO1999035248A3 (en) 1999-11-11
DK1047771T3 (da) 2003-08-11
AU2101599A (en) 1999-07-26
WO1999035248A2 (en) 1999-07-15
ES2198879T3 (es) 2004-02-01

Similar Documents

Publication Publication Date Title
DE60137203D1 (de) Poröse ferro- oder ferrimagnetische glasteilchen für molekültrennung
DK1106696T3 (da) Proteindeamiderende enzym, mikroorganisme producerende dette, gen kodende derfor, fremgangsmåde til fremstilling af enzymet og anvendelse deraf
ATE510023T1 (de) Enzyme mit alpha-amylase-aktivität und verfahren zu deren verwendung
WO2006127809A3 (en) Methods for expansion and analysis of cultured hematopoietic stem cells
IS5959A (is) Aðferð til hástigstjáningar virkra lífvessaeiturefnis-ß-þegaónæmisglóbúlínshermiprótína og hreinsunar þeirra
DE69905794D1 (de) Saure proteinhaltige Getränke und Verfahren zu ihrer Herstellung
ATE238414T1 (de) Verfahren zur angiostatinrückfaltung
AU4597599A (en) Device and method for the determination of protein domain boundaries
ATE278785T1 (de) Neues verfahren zur gewinnung und reinigung von fusionsproteinen
DE69637579D1 (de) Methode zur Amplifizierung von Nukleinsäure und entsprechende Regenzien dafür
ATE302844T1 (de) Verfahren zur aufreinigung eines enzyms und hiernach hergestelltes, aufgereinigtes enzym sowie verwendung des enzyms
DE69505076T2 (de) Trypsintyp-Enzyme, dafür kodierende Nukleinsäuresequenz und Verfahren zur Herstellung des Enzymes
ATE298794T1 (de) Verfahren zur herstellung und reinigung von sekretierten proteinen und herstellung von protein-arrays
ATE226254T1 (de) Reagenz zur behandlung von arthritischen zustaenden
DE60139544D1 (de) Veränderte, fluoreszierende proteine
DE69916593D1 (de) Verfahren zur cis-selektiven katalytischen hydrierung von cyclohexylidenaminen
DE60139635D1 (de) Verfahren zur produktion von plasminogen-kringle 2 plus serine protease domäne (k2s) im grossmassstab in prokaryonten
WO2003012089A3 (en) Crystal structure of beta-site app cleaving enzyme (bace) and use thereof
DE60035218D1 (de) Nukleinsäuren, welche für endotheliasen kodieren, endotheliasen, sowie deren verwendung
ATE332395T1 (de) Kulturmedium und verfahren zur bestimmung gram- negativer mikroorganismen
WO1999046384A3 (en) Human smad3 and smad4 are sequence-specific transcription activators
EP1141703A4 (de) Verfahren zum bestimmen eines erhöhten risikos einer frau ein "down-syndrom" zu tragen
ATE323173T1 (de) Nährboden zum nachweis und/oder zur unterscheidung von enterokokken
HK1070097A1 (en) Methods for large scale production of recombinant dna-derived tpa or k2s molecules
Vartio Gelatin‐degrading activity secreted by cultured macrophages from human blood

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee